✦ LIBER ✦

Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance

✍ Scribed by Carl J. Baldick; Daniel J. Tenney; Charles E. Mazzucco; Betsy J. Eggers; Ronald E. Rose; Kevin A. Pokornowski; Cheng F. Yu; Richard J. Colonno

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 401 KB
Volume: 47
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.22211

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro evaluation of hepatitis B virus

In vitro evaluation of hepatitis B virus polymerase mutations associated with famciclovir resistance

✍ Xiaofeng Xiong; Huiling Yang; Christopher E. Westland; Ruiming Zou; Craig S. Gib 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

Several mutations (V521L, P525L, L528M, T532S, and V555I) in the gene for hepatitis B virus (HBV) polymerase have been identified in HBV isolated from patients that displayed break-through viremia during famciclovir treatment. To determine whether these mutations cause phenotypic resistance to famci

Antiviral efficacy of combination therap

Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance

✍ Hyo-Joon Yang; Jeong-Hoon Lee; Yoon Jun Kim; Jung-Hwan Yoon; Hyo-Suk Lee 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract There is little clinical information on the management of hepatitis B virus (HBV) that is resistant to multiple drugs including entecavir (ETV). The present retrospective cohort study assessed the antiviral efficacy of ETV/adefovir dipivoxil (ADV) combination therapy for ETV‐resistant H

Characteristics of lamivudine-resistant

Characteristics of lamivudine-resistant hepatitis B virus (HBV) strains with and without breakthrough hepatitis in patients with chronic hepatitis B evaluated by serial HBV full-genome sequences

✍ Norio Horiike; Tran Nhu Duong; Kojiro Michitaka; Kouji Joko; Yoichi Hiasa; Ichir 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

## Abstract Lamivudine therapy often causes breakthrough of hepatitis B virus (HBV) DNA and breakthrough hepatitis. The aim of this study was to determine the viral factors that relate to HBV‐DNA breakthrough with and without breakthrough hepatitis. Among 82 patients with chronic hepatitis B (CHB)

Novel patterns of amino acid mutations i

Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in Japanese patients with chronic hepatitis B

✍ Ogata, Norio; Fujii, Kyuichi; Takigawa, Shingo; Nomoto, Minoru; Ichida, Takafumi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 2 views

Lamivudine is effective in suppressing replication of hepatitis B virus (HBV). However, the emergence of HBV variants resistant to lamivudine is a concern. Lamivudine resistance has been attributed mainly to a substitution of isoleucine or valine for methionine at residue 550 (M550I or M550V) in the

Frequent detection of hepatitis B virus

Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes

✍ S. Gloria Selabe; Ernest Song; Rosemary J. Burnett; M. Jeffrey Mphahlele 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

## Abstract This retrospective study investigated and characterized the YMDD motif of the hepatitis B virus (HBV) reverse transcriptase (RT) gene, in sequential samples of 17 South African patients with chronic hepatitis B infection on lamivudine treatment. The profile of HBV genotypes as well as t

Prediction of sustained virological resp

Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing

✍ Guy W. Neff; Christopher B. O'Brien; Robert Cirocco; Marzia Montalbano; Maria de 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

The optimal duration of therapy for pegylated interferon combined with ribavirin in recurrent Hepatitis C virus (HCV) following liver transplantation is not known. We wanted to determine if testing for HCV in liver tissue by reverse transcriptase polymerase chain reaction (RT-PCR) was superior in pr